Premium
Comparison of high‐dose salmeterol/fluticasone and moderate‐dose salmeterol/fluticasone plus low‐dose mometasone in patients with severe persistent asthma
Author(s) -
KURASHIMA KAZUYOSHI,
KAGIYAMA NAHO,
TAKAYANAGI NOBORU,
SUGITA YUTAKA
Publication year - 2011
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/j.1440-1843.2011.01967.x
Subject(s) - medicine , fluticasone , fluticasone propionate , salmeterol , asthma , corticosteroid , mometasone furoate , evening , morning , inhaled corticosteroids , anesthesia , physics , astronomy
Background and objective: The effects of adding a second inhaled corticosteroid with a different particle size, compared with using an increased dose of a single inhaled corticosteroid, were assessed in patients with persistent asthma. Methods: This was an open‐label study of Japanese asthma patients over 20 years of age. After a 1‐month run‐in period, 36 patients with inadequate control while using salmeterol/fluticasone propionate 50/250 µg (SFC50/250) bd, were randomized to receive SFC50/500 bd or SFC50/250 plus mometasone 100 µg bd (SFC50/250/MF100) for 2 months. Results: Both treatments resulted in improvements in morning and evening PEF. There were no significant changes in FEV 1 , maximum mid‐expiratory flow, maximum expiratory flow rate at 50%, maximum expiratory flow rate at 25% or exhaled NO (FENO) in the SFC50/500 group. On the other hand, there were significant improvements in FEV 1 % (+12.2%, P = 0.0142), %maximum mid‐expiratory flow (+28.9%, P = 0.0181), %MEF50 (+32.4%, P = 0.0206) and %MEF25 (+30.3%, P = 0.0113) in the SFC50/250/MF100 group. The changes in FENO (−23.2% ( P = 0.0157) in the SFC50/250/MF100 group and −14.5% (not significant) in the SFC50/500 group) did not differ significantly between the groups. Conclusions: In patients with severe persistent asthma, addition of low‐dose mometasone to SFC50/250 improved spirometric parameters, FENO and PEF, while an increase in dose from SFC50/250 to SFC50/ 500 only improved PEF.